Ticc Capital (TICC) Shareholder Muzinich & Company Has Cut Stake by $4.52 Million; Gilead Sciences (GILD) Shares Declined While Global Thematic Partners Has Lifted Position by $14.19 Million

November 15, 2017 - By reb123z

Muzinich & Company decreased its stake in Ticc Capital Corp (TICC) by 52.37% based on its latest 2017Q2 regulatory filing with the SEC. Muzinich & Company sold 753,930 shares as the company’s stock declined 9.22% while stock markets rallied. The institutional investor held 685,602 shares of the company at the end of 2017Q2, valued at $4.35M, down from 1.44 million at the end of the previous reported quarter. Muzinich & Company who had been investing in Ticc Capital Corp for a number of months, seems to be less bullish one the $311.45 million market cap company. It closed at $6.05 lastly. It is down 38.21% since November 15, 2016 and is uptrending. It has outperformed by 21.51% the S&P500.

Global Thematic Partners Llc increased its stake in Gilead Sciences Inc (GILD) by 24.03% based on its latest 2017Q2 regulatory filing with the SEC. Global Thematic Partners Llc bought 202,758 shares as the company’s stock declined 8.05% while stock markets rallied. The institutional investor held 1.05M shares of the health care company at the end of 2017Q2, valued at $74.07 million, up from 843,739 at the end of the previous reported quarter. Global Thematic Partners Llc who had been investing in Gilead Sciences Inc for a number of months, seems to be bullish on the $92.92 billion market cap company. The stock declined 0.91% or $0.65 reaching $70.5 on the news. About 37,758 shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since November 15, 2016 and is downtrending. It has underperformed by 38.50% the S&P500.

Investors sentiment increased to 0.93 in 2017 Q2. Its up 0.02, from 0.91 in 2017Q1. It increased, as 78 investors sold GILD shares while 538 reduced holdings. 110 funds opened positions while 462 raised stakes. 938.32 million shares or 0.11% more from 937.32 million shares in 2017Q1 were reported. Moreover, First Retail Bank Of Omaha has 0.01% invested in Gilead Sciences, Inc. (NASDAQ:GILD). 156,609 were accumulated by Robecosam Ag. Reilly Financial Ltd Liability invested 0.01% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Grandfield And Dodd Ltd stated it has 101,903 shares or 0.85% of all its holdings. Moreover, Prudential Fincl Incorporated has 0.35% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 3.29 million shares. Rafferty Asset Mgmt Limited Liability Co reported 22,306 shares or 0.05% of all its holdings. Pennsylvania Tru Co holds 0.53% or 152,251 shares. Alabama-based Cabot has invested 6.03% in Gilead Sciences, Inc. (NASDAQ:GILD). Carnegie Asset Mngmt Llc owns 8,553 shares. Ajo LP reported 0.73% in Gilead Sciences, Inc. (NASDAQ:GILD). American Financial Grp Inc reported 120,000 shares. Advisors owns 6,020 shares for 0.46% of their portfolio. Sumitomo Life Ins accumulated 28,771 shares. Shoker Inv Counsel invested 0.24% in Gilead Sciences, Inc. (NASDAQ:GILD). Tiger Llc owns 38,511 shares.

Since June 1, 2017, it had 0 buys, and 2 sales for $5.11 million activity. $4.78M worth of Gilead Sciences, Inc. (NASDAQ:GILD) shares were sold by MARTIN JOHN C.

Global Thematic Partners Llc, which manages about $12.76 billion and $3.11 billion US Long portfolio, decreased its stake in Aramark (NYSE:ARMK) by 42,162 shares to 1.83M shares, valued at $74.87 million in 2017Q2, according to the filing. It also reduced its holding in Comcast Corp New (NASDAQ:CMCSA) by 44,325 shares in the quarter, leaving it with 2.02 million shares, and cut its stake in Fortinet Inc (NASDAQ:FTNT).

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: Fool.com which released: “What’s Behind Gilead Sciences Inc.’s $7.8 Billion Slide in October?” on November 02, 2017, also Nasdaq.com with their article: “Gilead Sciences Inc. Q3 Earnings Drop 19%” published on October 26, 2017, Seekingalpha.com published: “Gilead: A Buy After Earnings” on October 27, 2017. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: Seekingalpha.com and their article: “Gilead: The Turnaround Begins” published on October 19, 2017 as well as Finance.Yahoo.com‘s news article titled: “Gilead Sciences Inc. Still Singing the HCV Blues in the 3rd Quarter” with publication date: October 26, 2017.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 18 have Buy rating, 0 Sell and 12 Hold. Therefore 60% are positive. Gilead Sciences had 106 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was downgraded by Maxim Group on Friday, April 29 to “Hold”. The stock has “Buy” rating by Cowen & Co on Monday, September 21. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Hold” rating by Jefferies on Friday, October 27. The rating was maintained by RBC Capital Markets on Wednesday, October 4 with “Buy”. The firm has “Overweight” rating given on Thursday, November 5 by Piper Jaffray. The firm has “Hold” rating by Maxim Group given on Tuesday, May 30. The firm has “Outperform” rating by BMO Capital Markets given on Friday, October 27. Oppenheimer maintained Gilead Sciences, Inc. (NASDAQ:GILD) rating on Wednesday, July 29. Oppenheimer has “Outperform” rating and $120 target. On Wednesday, January 20 the stock rating was initiated by Credit Suisse with “Outperform”. Jyske Bank upgraded the stock to “Strong Buy” rating in Thursday, September 10 report.

Investors sentiment decreased to 2.22 in 2017 Q2. Its down 0.25, from 2.47 in 2017Q1. It is negative, as 3 investors sold TICC shares while 15 reduced holdings. 16 funds opened positions while 24 raised stakes. 7.82 million shares or 0.23% less from 7.84 million shares in 2017Q1 were reported. 109,300 are held by Arrowstreet Capital Limited Partnership. Shufro Rose & Ltd holds 17,000 shares or 0.01% of its portfolio. Tudor Investment Et Al reported 31,446 shares or 0.01% of all its holdings. Texas Yale has invested 0.08% in TICC Capital Corp. (NASDAQ:TICC). Deutsche Financial Bank Ag reported 11,100 shares stake. Two Sigma Secs Ltd Llc reported 0.04% of its portfolio in TICC Capital Corp. (NASDAQ:TICC). Moreover, Legal And General Public Limited Liability has 0% invested in TICC Capital Corp. (NASDAQ:TICC) for 127,827 shares. Mackenzie Fincl holds 34,334 shares or 0% of its portfolio. 16,712 were reported by Bluecrest Mngmt. Sather Fin Gru reported 0.07% of its portfolio in TICC Capital Corp. (NASDAQ:TICC). Pinebridge Invs Limited Partnership owns 409 shares or 0% of their US portfolio. Raymond James Financial Service Advisors has invested 0% of its portfolio in TICC Capital Corp. (NASDAQ:TICC). Eagle Glob Ltd Liability Co, a Texas-based fund reported 107,689 shares. Optimum Investment Advsr stated it has 0.07% of its portfolio in TICC Capital Corp. (NASDAQ:TICC). Wealthtrust reported 1,652 shares.

Muzinich & Company, which manages about $22.20 billion and $1.14B US Long portfolio, upped its stake in Main Street Capital Corp (NYSE:MAIN) by 133,731 shares to 2.31 million shares, valued at $88.97 million in 2017Q2, according to the filing. It also increased its holding in Goldman Sachs Bdc Inc by 131,366 shares in the quarter, for a total of 1.44M shares, and has risen its stake in Tpg Specialty Lending In (NYSE:TSLX).

Among 7 analysts covering TICC Capital (NASDAQ:TICC), 1 have Buy rating, 2 Sell and 4 Hold. Therefore 14% are positive. TICC Capital had 9 analyst reports since August 5, 2015 according to SRatingsIntel. As per Tuesday, March 7, the company rating was downgraded by National Securities. The firm has “Buy” rating given on Monday, November 6 by Ladenburg Thalmann. The rating was maintained by Barclays Capital with “Equal-Weight” on Friday, March 11. Maxim Group downgraded the shares of TICC in report on Wednesday, August 5 to “Hold” rating. As per Wednesday, May 4, the company rating was downgraded by Barclays Capital.

More notable recent TICC Capital Corp. (NASDAQ:TICC) news were published by: Seekingalpha.com which released: “TICC Capital’s (TICC) CEO Jonathan Cohen on Q2 2017 Results – Earnings Call …” on August 08, 2017, also Nasdaq.com with their article: “Bull Of The Day: TICC Capital Corp” published on July 06, 2017, Nasdaq.com published: “TICC Capital Corp. (TICC) Ex-Dividend Date Scheduled for June 14, 2017” on June 13, 2017. More interesting news about TICC Capital Corp. (NASDAQ:TICC) were released by: Seekingalpha.com and their article: “TICC Capital: Preliminary Proxy Reveals Advisor’s Ambitions” published on May 31, 2017 as well as Nasdaq.com‘s news article titled: “TICC Capital Corp. (TICC) Ex-Dividend Date Scheduled for September 14, 2017” with publication date: September 13, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts